182 related articles for article (PubMed ID: 22149276)
1. Monoclonal antibodies against recombinant histidine-rich protein 2 of Plasmodium falciparum and their use in malaria diagnosis.
Merwyn S; Gopalan N; Singh AK; Rai GP; Agarwal GS
Hybridoma (Larchmt); 2011 Dec; 30(6):519-24. PubMed ID: 22149276
[TBL] [Abstract][Full Text] [Related]
2. Novel monoclonal antibody against truncated C terminal region of Histidine Rich Protein2 (PfHRP2) and its utility for the specific diagnosis of malaria caused by Plasmodium falciparum.
Verma R; Jayaprakash NS; Vijayalakshmi MA; Venkataraman K
Exp Parasitol; 2015 Mar; 150():56-66. PubMed ID: 25592728
[TBL] [Abstract][Full Text] [Related]
3. Quantification of Histidine-Rich Protein 3 of Plasmodium falciparum.
Palani B
Monoclon Antib Immunodiagn Immunother; 2018 Apr; 37(2):87-90. PubMed ID: 29634395
[TBL] [Abstract][Full Text] [Related]
4. Adjuvant poly(N-isopropylacrylamide) generates more efficient monoclonal antibodies against truncated recombinant histidine-rich protein2 of Plasmodium falciparum for malaria diagnosis.
Verma R; Ravichandran R; Jayaprakash NS; Kumar A; Vijayalakshmi MA; Venkataraman K
Biotechnol J; 2015 May; 10(5):772-82. PubMed ID: 25641957
[TBL] [Abstract][Full Text] [Related]
5. Passive transfer of Plasmodium falciparum MSP-2 pseudopeptide-induced antibodies efficiently controlled parasitemia in Plasmodium berghei-infected mice.
Martínez PA; Yandar N; Lesmes LP; Forero M; Pérez-Leal O; Patarroyo ME; Lozano JM
Peptides; 2009 Feb; 30(2):330-42. PubMed ID: 19071172
[TBL] [Abstract][Full Text] [Related]
6. Immunogenicity of a recombinant malaria vaccine candidate, domain I+II of AMA-1 ectodomain, from Indian P. falciparum alleles.
Lalitha PV; Biswas S; Pillai CR; Saxena RK
Vaccine; 2008 Aug; 26(35):4526-35. PubMed ID: 18590786
[TBL] [Abstract][Full Text] [Related]
7. Immunogenicity and antigenic properties of Pf332-C231, a fragment of a non-repeat region of the Plasmodium falciparum antigen Pf332.
Balogun HA; Vasconcelos NM; Lindberg R; Haeggström M; Moll K; Chen Q; Wahlgren M; Berzins K
Vaccine; 2009 Dec; 28(1):90-7. PubMed ID: 19822232
[TBL] [Abstract][Full Text] [Related]
8. Antibodies from malaria-exposed pregnant women recognize trypsin resistant epitopes on the surface of Plasmodium falciparum-infected erythrocytes selected for adhesion to chondroitin sulphate A.
Sharling L; Enevold A; Sowa KM; Staalsoe T; Arnot DE
Malar J; 2004 Sep; 3():31. PubMed ID: 15350207
[TBL] [Abstract][Full Text] [Related]
9. Correlation of high levels of antibodies to multiple pre-erythrocytic Plasmodium falciparum antigens and protection from infection.
John CC; Moormann AM; Pregibon DC; Sumba PO; McHugh MM; Narum DL; Lanar DE; Schluchter MD; Kazura JW
Am J Trop Med Hyg; 2005 Jul; 73(1):222-8. PubMed ID: 16014863
[TBL] [Abstract][Full Text] [Related]
10. [Preparation and characterization of monoclonal antibodies against erythrocyte-binding antigen 175 of Plasmodium falciparum].
Hao WB; Hong YH; Sun XM; Ning Y; Zhang DM; Pan WQ; Li M
Di Yi Jun Yi Da Xue Xue Bao; 2005 Sep; 25(9):1169-71. PubMed ID: 16174591
[TBL] [Abstract][Full Text] [Related]
11. Immunization with recombinant duffy binding-like-gamma3 induces pan-reactive and adhesion-blocking antibodies against placental chondroitin sulfate A-binding Plasmodium falciparum parasites.
Costa FT; Fusaï T; Parzy D; Sterkers Y; Torrentino M; Douki JB; Traoré B; Petres S; Scherf A; Gysin J
J Infect Dis; 2003 Jul; 188(1):153-64. PubMed ID: 12825185
[TBL] [Abstract][Full Text] [Related]
12. Development, purification, and characterization of monoclonal antibodies against recombinant histidine-rich protein 3 of Plasmodium falciparum.
Palani B; Ranjini SS; Jayaprakash NS; Vijayalakshmi MA
Monoclon Antib Immunodiagn Immunother; 2013 Oct; 32(5):341-8. PubMed ID: 24111866
[TBL] [Abstract][Full Text] [Related]
13. New developments in malaria diagnostics: monoclonal antibodies against Plasmodium dihydrofolate reductase-thymidylate synthase, heme detoxification protein and glutamate rich protein.
Kattenberg JH; Versteeg I; Migchelsen SJ; González IJ; Perkins MD; Mens PF; Schallig HD
MAbs; 2012; 4(1):120-6. PubMed ID: 22327435
[TBL] [Abstract][Full Text] [Related]
14. Antibody and cellular immune responses to Plasmodium falciparum histidine-rich protein II in malaria-exposed individuals in Orissa, India.
Das P; Grewal JS; Chauhan VS
Trans R Soc Trop Med Hyg; 2010 May; 104(5):371-3. PubMed ID: 20116080
[TBL] [Abstract][Full Text] [Related]
15. A Plasmodium falciparum GLURP-MSP3 chimeric protein; expression in Lactococcus lactis, immunogenicity and induction of biologically active antibodies.
Theisen M; Soe S; Brunstedt K; Follmann F; Bredmose L; Israelsen H; Madsen SM; Druilhe P
Vaccine; 2004 Mar; 22(9-10):1188-98. PubMed ID: 15003647
[TBL] [Abstract][Full Text] [Related]
16. Antigenic cross-reactivity between different alleles of the Plasmodium falciparum merozoite surface protein 2.
Felger I; Steiger S; Hatz C; Smith T; Beck HP
Parasite Immunol; 2003; 25(11-12):531-43. PubMed ID: 15053774
[TBL] [Abstract][Full Text] [Related]
17. Production and characterization of specific monoclonal antibodies binding the Plasmodium falciparum diagnostic biomarker, histidine-rich protein 2.
Leow CH; Jones M; Cheng Q; Mahler S; McCarthy J
Malar J; 2014 Jul; 13():277. PubMed ID: 25037150
[TBL] [Abstract][Full Text] [Related]
18. Effect of sequence variation in Plasmodium falciparum histidine- rich protein 2 on binding of specific monoclonal antibodies: Implications for rapid diagnostic tests for malaria.
Lee N; Baker J; Andrews KT; Gatton ML; Bell D; Cheng Q; McCarthy J
J Clin Microbiol; 2006 Aug; 44(8):2773-8. PubMed ID: 16891491
[TBL] [Abstract][Full Text] [Related]
19. Immunogenicity of synthetic peptides derived from Plasmodium falciparum proteins.
Zerpa NC; Wide A; Noda J; Bermúdez H; Pabón R; Noya OO
Exp Parasitol; 2006 Aug; 113(4):227-34. PubMed ID: 16513113
[TBL] [Abstract][Full Text] [Related]
20. Immunogenicity of the Plasmodium falciparum PfEMP1-VarO Adhesin: Induction of Surface-Reactive and Rosette-Disrupting Antibodies to VarO Infected Erythrocytes.
Guillotte M; Juillerat A; Igonet S; Hessel A; Petres S; Crublet E; Le Scanf C; Lewit-Bentley A; Bentley GA; Vigan-Womas I; Mercereau-Puijalon O
PLoS One; 2015; 10(7):e0134292. PubMed ID: 26222304
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
